| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 92,413 | 93,771 | 97,744 | 143,768 | | Cost of Revenue | 74,655 | 80,939 | 84,062 | 123,763 | | | Gross Profit | 17,758 | 12,832 | 13,682 | 20,005 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,068 | 8,612 | 9,027 | 11,552 | | Non Recurring |
-
|
-
|
-
| 3,495 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,690 | 4,220 | 4,655 | 4,958 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,479 | 398 | 438 | 4,058 | | Earnings Before Interest And Taxes | 10,169 | 4,618 | 5,093 | 9,016 | | Interest Expense | 328 | 333 | 328 | 452 | | Income Before Tax | 9,841 | 4,285 | 4,765 | 8,564 | | Income Tax Expense | 3,697 | 1,633 | 1,746 | 2,907 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,144 | 2,652 | 3,019 | 5,657 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,144 | 2,652 | 3,019 | 5,657 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,144 | $2,652 | $3,019 | $5,657 |
|
1.52% Nasdaq 
Income Statement
